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Backgrounds: In vitro fertilization involves high dosage gonadotropin stimulation, which apparently has some
negative impact on follicular endocrine function. As chorionic gonadotropin stimulation has been shown to
increase the blood-follicular permeability in animal models, this raises the question if such an effect also applies to
gonadotropins in humans, possibly affecting the endocrine follicular milieu.
Findings: Follicular fluid and serum were collected at the time of follicular aspiration in in vitro fertilisation without
(Natural cycle IVF, n = 24) and with (conventional gonadotropin stimulated IVF, n = 31) gonadotropin stimulation.
The concentration of the extra-ovarian hormones prolactin and cortisol were analysed by immunoassays.
Results: Median serum prolactin and cortisol concentrations were 12.3 ng/mL and 399 nmol/L without versus
32.2 ng/mL and 623 nmol/L with gonadotropin stimulation. The corresponding concentrations in follicular fluid
were 20.6 ng/mL and 445 nmol/L versus 28.8 ng/ml and 456 nmol/L for prolactin and cortisol. As a consequence,
mean follicular fluid:serum ratios were significantly reduced under gonadotropin stimulation (prolactin p = 0.0138,
cortisol p = 0.0001). As an enhanced blood-follicular permeability and transportation, induced by gonadotropin
stimulation, would result in increased instead of decreased follicular fluid:serum ratios as found in this study, it
can be assumed that this does not affect extra-ovarian protein and steroid hormones as illustrated by prolactin
and cortisol.
Conclusions: The model of serum follicular fluid:serum ratio of hormones, produced outside the ovaries, did not
reveal a gonadotropin induced increased blood-follicular transportation capacity. Therefore it can be assumed that
the effect of gonadotropins on follicular endocrine function is not due to an increased ovarian permeability of
extra-ovarian hormones.
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Background
Ovarian follicles are regulated by different hormones acting
directly or indirectly on theca cells outside or on granulosa
cells inside the follicle. Unaffected transportation of
these hormones into the follicle is highly relevant as a
decreased hormone concentration in follicular fluid (FF)
might negatively influence follicular function. Accordingly,* Correspondence: Michael.vonWolff@insel.ch
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reproduction in any medium, provided the ortransportation deficits as a source of follicular dysfunction
have been suggested.
In conventional In vitro Fertilization (cIVF), high
dosages of gonadotropins are used to induce a multi-
follicular reaction. Gonadotropin stimulation has also
many effects on follicular function such as changes in
the metabolism of the follicles, possibly being one of the
reasons for the suggested lower implantation rates of
embryos in cIVF in comparison with those in Natural
Cycle-IVF (NC-IVF) without any exogenous gona-
dotropin stimulation [1,2]. Furthermore, animal studiesral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reduced the resistance of blood-ovarian barrier and
thereby increased the influx of microspheres and mole-
cules into the follicles [3,4]. These studies raised the
question whether such an effect also applies to gona-
dotropin stimulation resulting in an increase of the
concentration of follicle regulating hormones such as
prolactin and cortisol.
We therefore analysed serum (S) and FF concentra-
tions of prolactin and cortisol in cIVF-follicles, aspirated
after hCG triggering and calculated the FF:S ratio. As a
reference model we used follicles from NC-IVF-therap-
ies. We chose prolactin and cortisol, as both these hor-
mones are not (cortisol) or hardly (prolactin) produced
by the follicles and as they have been shown to be rele-
vant for follicular regulation.
Methods
Fifty-five women underwent either cIVF (n = 31) or NC-
IVF (n = 24) according to their personal preference. For
cIVF, the antagonist protocol was used. The study was
approved by the local ethical committee and patient’s
approval was given by written consent. HMG (150 to
300 IU per day of human menopausal gonadotropin,
Menogon HP®, Ferring AG, Baar, Switzerland) treatment
was initiated between day 3–5 of the menstrual cycle.
GnRH antagonists (Orgalutran®, MSD Merck Sharp &
Dohme GmbH, Lucerne, Switzerland) were first adminis-
tered between day 6–7 of the menstrual cycle and contin-
ued until ovulation induction. Once an adaequate ovarian
response had been confirmed, urinary human chorionic
gonadotropin (hCG) (Predalon®, MSD Merck Sharp &
Dohme GmbH, Lucerne, Switzerland) were administered
to induce ovulation 36 hours before oocyte retrieval.
NC-IVF patients were monitored by ultrasound and
analysis of luteinizing hormone and 17β-estradiol (E2)
concentrations. When the follicle diameter reached at
least 18 mm and E2-concentration was above 800 pmol/L,
hCG were administered 36 hours before oocyte retrieval.
Follicle aspirations in both cIVF and NC-IVF were sche-
duled in the morning to avoid variations of cortisol con-
centrations due to its circadian release pattern.
The cumulus oophorus complex was isolated and the
FF clarified by centrifugation, and stored at −30°C until
further analysis. Venous blood was collected at the time
of follicle aspiration and serum was stored at −30°C.
Prolactin and cortisol concentrations were analysed by
electrochemiluminescent immunoassay (ECLIA) on a
COBAS 6000 (e601Modul) (Roche Diagnostics GmbH,
Mannheim, Germany). The interassay variations of the
assays were less than 4%.
Statistical analyses were performed by Mann–Whitney
U test for comparisons of hormone levels between
the two patient groups, and by Student t-test for thecomparisons of the FF:Serum ratios as these latter were
found to be normally distributed.
Results
Mean patient age was 34.9 (SD 4.9, range 21–42) years
for the NC-IVF and 33.8 (SD 3.7, range 25–41) years for
the cIVF group. Concentration of anti mullerian hormone
(AMH) was 17.7 (SD 14.6) and 22.9 (SD 15.3) and mean
follicle size at the time of aspiration was 19.6 (SD 1.2) and
19.5 (SD 1.2) mm, respectively. Body mass index in all
patients was between 20 and 30.
Median serum prolactin concentrations were 12.3
(range 5.8–50.7) ng/mL in the NC-IVF and around 3-
fold higher (median 32.2, range 8.3–261.6 ng/ml) in the
cIVF group (p = 0.0002). The same pattern was observed
for cortisol; in NC-IVF the serum concentrations were
399 (range 132–735) nmol/L and in cIVF they were
higher (median 623, range 253–928 nmol/L (p = 0.0001).
In the FF, the increased concentrations of prolactin and
cortisol in the cIVF over the NC group were less pro-
nounced (and statistically significant only for prolactin)
when compared to the observations in serum. Median
FF prolactin levels were 20.6 (range 0.4–80.5) ng/mL in
NC-IVF and 28.8 (range 2.7–71.1) ng/mL in cIVF (p =
0.0164), and median FF cortisol concentrations were 445
(range 23–657) nmol/L in NC-IVF and 456 (69–631)
nmol/L in cIVF. Serum and FF prolactin and cortisol
concentrations are shown as box-and-whisker plots in
Figure 1a.
The average FF:S ratios were significantly lower in
cIVF than in NC-IVF for both hormones. For prolactin,
the mean FF:S ratio was 1.5 (SD, 0.8) in NC-IVF and 1.0
(SD, 0.7) in cIVF (p = 0.0138). For cortisol, the mean FF:
S ratios were 1.0 (SD, 0.3) and 0.7 (SD, 0.3) for NC-IVF
and cIVF, respectively (p = 0.0001). These results are
illustrated as scatter plots in Figure 1b.
Discussion
Gonadotropins have been associated with several effects
on follicular function. Recent research comparing the
protein contents of follicles following conventional go-
nadotropin stimulation in IVF compared with naturally
matured follicles has shown differences in the endocrine
milieu. In conventional IVF androgens as well as AMH,
which has been shown to be a marker of oocyte quality
have been found to be much lower concentrated in fol-
licular fluids at the time of follicle aspiration [5,6].
As gonadotropins seem to have a substantial effect on
the follicular endocrine milieu, it is of interest, if this
effect is also based on an effect of gonadotropins on the
blood-follicular transportation capacity and permeability.
In mice [3] and in rats [4] chorionic gonadotropins
induced an increase of molecular blood-ovarian perme-
ability and transportation capacity by raising ovarian
Figure 1 Prolactin and cortisol in serum and follicular fluid in cIVF and NC-IVF. (a). Box-and-whisker plot of prolactin and cortisol
concentrations in natural IVF (NC, fine lines) and conventional, gonadotropin stimulated IVF (cIVF, bold lines) cycles in serum (S, open boxes) and
in follicular fluid (FF, hatched boxes). Boxes represent the 25th, 50th (median), and 75th centiles, the whiskers indicate the minimum and
maximum levels. (b). Scatterplot of individual FF:S ratios in conventional, gonadotropin stimulated IVF (cIVF, closed circles) compared to natural
IVF (NC, open circles). The solid horizontal lines indicate the medians. Please note the logarithmic scale in both panels (a) and (b).
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crease in permeability is modulated mainly through
increased numbers of large capillary pores, similar to a
classical inflammatory response [4]. Furthermore, it
seems to be charge and size specific as in mice nega-
tively charged inter-α-inhibitor entered the follicle only
after preovulatory stimulation by chorionic gonadotro-
pins and passage of intermediate-size molecules was also
chorionic gonadotropin dependant [3].
These findings are limited to animal studies and to
stimulation with chorionic gonadotropins but do not
involve gonadotropins such as follicle stimulating hormo-
ne (FSH) or human menopausal gonadotropin (HMG) as
used in IVF therapies. Furthermore, in humans such in-
vestigations are difficult to perform and any results will
only apply to the specific molecules involved in the ana-
lysis. Therefore, studies should directly involve substances
of interest which play a role in ovarian function and which
are not or hardly produced by the follicles. These criteria
apply to prolactin [7], produced by the pituitary gland and
to cortisol [8], produced by the adrenal cortex.
We chose the FF:S ratio as a parameter for the serum-
ovarian transportation capacity and speculated that this
parameter would be higher if the permeability increased
due to gonadotropins. Our study revealed exactly the
opposite. The FF:S ratio was lower in gonadotropin
stimulated cIVF than in NC-IVF patients.
These surprising results might theoretically be due to
the following effects: First, the conversion of the studied
molecules is activated by gonadotropin stimulation lead-
ing to lower FF concentrations; secondly, the result is due
to increased serum concentrations, altering the ratios andthirdly the blood ovarian transportation capacity is not
increased but decreased by gonadotropins.
For prolactin, no specific enzymes are known which
could convert this molecule, resulting in an accelerated
gonadotropin induced degradation of the molecule. In
contrast, for cortisol an enzyme which converts cortisol in
cortisone is known. The enzyme 11betaHSD, expressed by
granulosa cells, is downregulated by hCG [9]. Andersen
et al. analysed cortisol and cortisone in follicular fluid and
found similar cortisol concentration in FF in NC-IVF and
cIVF-follicles following ovulation induction with hCG [10].
Higher serum concentration of prolactin and cortisol
in cIVF might affect the FF:S ratio. However, as we
postulate that an increase of prolactin and cortisol in
serum should result in similar relative increase of
intrafollicular concentration, these differences in serum
concentrations should have only minor effects on our
study results.
It can therefore be assumed that the influence of the
factors “conversion” and “increased serum concentra-
tions” should have only limited effect on the FF:S ratio,
allowing this ratio to be used as a indirect parameter for
the analysis of the gonadotropin dependant blood-
ovarian permeability of prolactin and cortisol.
As we have stated above, a gonadotropin induced
increase of the blood-ovarian permeability should result
in an increase of the FF:S ratio. However, we have found
exactly the opposite i.e. a significant decrease of the ra-
tio. Even many other factors might affect intrafollicular
concentrations and thereby the FF:S ratio, we can most
certainly conclude that gonadotropins did not increase
the blood-follicular transportation capacity, as we would
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the cIVF group.
In summary, our model should allow the conclusion
that gonadotropin stimulation does not increase the
transportation of prolactin and cortisol into the follicle.
This effect might possibly also apply to other hormones
regulating ovarian function. It can therefore be assumed
that the above mentioned negative effects of gonadotro-
pins on follicular function are not due to an increase in
blood-ovarian permeability, as it has been previously
described in animal studies.
Conclusions
The model of serum follicular fluid:serum ratio of hor-
mones, produced outside the ovaries, did not reveal an
gonadotropin induced increased follicular permeability.
Therefore it can be assumed that the effect of gonado-
tropins on follicular endocrine function is not due to an
increased permeability of extra-ovarian hormones.
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